Chronic ethanol exposure changes dopamine D2 receptor splicing during retinoic acid-induced differentiation of human SH-SY5Y cells

Pharmacological Reports

Volumn 62, Issue 4, 2010, Pages 649-663

  Wernicke, Catrin ^a   Hellmann, Julian ^a   Finckh, Ulrich ^b   Rommelspacher, Hans ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Alcohol withdrawal; Chronic ethanol; DAT; Development; Differentiation; Dopamine D2 receptor; Human neuroblastoma cells; Splice variants

Indexed keywords

ALCOHOL; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; RETINOIC ACID;

ALCOHOL WITHDRAWAL; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DOPAMINE UPTAKE; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LONG TERM EXPOSURE; NERVE CELL DIFFERENTIATION; NEURITE; NEUROBLASTOMA CELL; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; WESTERN BLOTTING; ALTERNATIVE RNA SPLICING; BIOLOGICAL MODEL; CELL DIFFERENTIATION; DRUG EFFECT; GENETICS; METABOLISM; NEUROBLASTOMA; PATHOPHYSIOLOGY; TUMOR CELL LINE; UPREGULATION; WITHDRAWAL SYNDROME;

ALTERNATIVE SPLICING; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE, TUMOR; DOWN-REGULATION; ETHANOL; HUMANS; MODELS, BIOLOGICAL; NEUROBLASTOMA; RECEPTORS, DOPAMINE D2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUBSTANCE WITHDRAWAL SYNDROME; TRETINOIN; UP-REGULATION;

EID: 77957973745     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(10)70322-4     Document Type: Article

References (66)

1. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidmann JG, Smith JG, Smith JA et al.: Chapter 10: Analysis of proteins., pp. 10.8.8-10.8.9., in Current Protocols in Molecular Biology, John Wiley and Sons, Inc., New York, 2000.
2. Akker SA, Smith PJ, Chew SL: Nuclear post-transcriptional control of gene expression. J Mol Endocrinol, 2001, 27, 123-131.
3. Becker HC, Weathersby RT, Hale RL: Prenatal ethanol exposure alters sensitivity to the effects of apomorphine given alone and in combination with ethanol on locomotor activity in adult male mouse offspring. Neurotoxicol Teratol, 1995, 17, 57-64.
4. Bice PJ, Liang T, Zhang L, Strother WN, Carr LG:.Drd2 expression in the high alcohol-preferring and low alcohol-preferring mice. Mamm Genome, 2008, 19, 669-676.
5. Biedler JL, Helson L, Spengler BA: Morphology and growth, tumorigenicity, and cytogenetics of human neuroblstoma cells in continous culture. Cancer Res, 1973, 33, 2643-2652.
6. Biedler JL, Roffler-Tarlov S, Schachner M, Freedman LS: Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res, 1978, 38, 3751-3757.
7. Boggan WO, Xu W, Shepherd CL, Middaugh LD: Effects of prenatal ethanol exposure on dopamine systems in C57BL/6J mice. Neurotoxicol Teratol, 1996, 18, 41-48.
8. Bolan EA, Kivell B, Jaligam V, Oz M, Jayanthi LD, Han Y, Sen N et al.: D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism. Mol Pharmacol, 2007, 71, 1222-1232.
9. Clagett-Dame M, McKelvy JF: N-linked oligosaccharides are responsible for rat striatal dopamine D2 receptor heterogeneity. Arch Biochem Biophys, 1989, 274, 145-154.
10. Cunningham CL, Howard MA, Gill SJ, Rubinstein M, Low MJ, Grandy DK: Ethanol-conditioned place preference is reduced in dopamine D2 receptor-deficient mice. Pharmacol Biochem Behav, 2000, 67, 693-699.
11. Druse-Manteuffel M: Neurotransmitter function: changes associated with in utero alcohol exposure. In: Fetal Alcohol Syndrome: from Mechanism to Prevention. Ed. Abel EL, CRC Press, Boca Raton, 1996, 171-189.
12. Encinas M, Iglesias M, Liu Y, Wang H, Muhaisen A, Cena V, Gallego C et al.: Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factordependent, human neuron-like cells. J Neurochem, 2000, 75, 991-1003.
13. Farooqui SM, Prasad C, Ali M: Production and characterization of a monoclonal antibody to dopamine D2 receptor: comparison with a polyclonal antibody to a different epitope. Biochem Biophys Res Commun, 1992, 184, 661-667.
14. Farooqui SM: Induction of adenylate cyclase sensitive dopamine D2-receptors in retinoic acid induced differentiated human neuroblastoma SHSY-5Y cells. Life Sci, 1994, 55,1887-1893.
15. Gingrich JA, Caron MG: Recent advances in the molecular biology of dopamine receptors. Annu Rev Neurosci, 1993, 16, 299-321.
16. Gonzales RA, Job MO, Doyon WM: The role of mesolimbic dopamine in the development and maintenance of ethanol reinforcement. Pharmacol Ther, 2004, 103, 121-46.
17. Hamann J, Rommelspacher H, Storch A, Reichmann H, Gille G: Neurotoxic mechanisms of 2,9-dimethyl--carbolinium ion in primary dopaminergic culture. J Neurochem, 2006, 98,1185-1199.
18. Hannigan JH, Blanchard BA, Horner MP, Riley EP, Pilati ML: Apomorphine-induced motor behavior in rats exposed prenatally to alcohol. Neurotoxicol Teratol, 1990, 12, 79-84.
19. 18F]DMFP PET study in detoxified alcoholic patients. Am J Psychiatry, 2005, 162, 1515-1520.
20. 2 receptors in the ventral striatum and central processing of alcohol cues and craving. Am J Psychiatry, 2004, 161, 1783-1789.
21. Hellmann J, Rommelspacher H, Wernicke C: Long-term ethanol exposure impairs neuronal differentiation of human neuroblastoma cells involving neurotrophinmediated intracellular signaling and in particular protein kinase C. Alcohol Clin Exp Res, 2009, 33, 538-550.
22. Kaplan DR, Matsumoto K, Lucarelli E, Thiele CJ: Induction of TrkB by retinoic acid mediates biologic responsiveness to BDNF and differentiation of human neuroblastoma cells. Eukaryotic Signal Transduction Group. Neuron, 1993, 11, 321-331.
23. Khan ZU, Mrzljak l, Gutierrez A, de la Calle A, Goldman-Rakic P: Prominence of the dopamine D2 short isoform in dopaminergic pathways. Proc Natl Acad Sci, USA, 1998, 95, 7731-7736.
24. Kim MO, Lee YK, Choi WS, Kim JH, Hwang SK, Lee BJ, Kang SG et al.: Prolonged ethanol intake increases D2 dopamine receptor expression in the rat brain. Mol Cells, 1997, 7, 682-687.
25. Koob GF, Bloom FE: Cellular and molecular mechanisms of drug dependence. Science, 1988, 242, 715-723.
26. Kraschewski A, Reese J, Anghelescu I, Winterer G, Schmidt LG, Gallinat J, Finckh U et al.: Association of the dopamine D2 receptor gene with alcohol dependence: haplotypes and subgroups of alcoholics as key factors for understanding receptor function. Pharmacogen Genom, 2009, 19, 513-527.
27. Krause KH, Dresel SH, Krause J, Kung HF, Tatsch K, Ackenheil M: Stimulant-like action of nicotine on striatal dopamine transporter in the brain of adults with attention deficit hyperactivity disorder. Int J Neuropsychopharmacol, 2002, 5, 111-113.
28. Lee FJ, Pei L, Moszczynska A, Vukusic B, Fletcher PJ, Liu F: Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor. EMBO J, 2007, 26, 2127-2136.
29. -δδCT method. Methods, 2001, 25, 402-408.
30. Lorenc-Koci E, Rommelspacher H, Schulze G, Wernicke C, Kuter K, Smialowska M, Wieronska J et al.: Parkinson' s disease-like syndrome in rats induced by 2,9-dimethyl-carbolinium ion, a -carboline occurring in the human brain. Behav Pharmacol, 2006, 17, 463-473.
31. Lucchi L, Covelli V, Petkov VV, Spano PF, Trabucchi M: Effects of ethanol, given during pregnancy, on the offspring dopaminergic system. Pharmacol Biochem Behav, 1983, 19, 567-570.
32. Maltais S, Côté S, Drolet G, Falardeau P: Cellular colocalization of dopamine D1 mRNA and D2 receptor in rat brain using a D2 dopamine receptor specific polyclonal antibody. Prog Neuropsychopharmacol Biol Psychiatry, 2000, 24, 1127-1149.
33. Mercuri NB, Saiardi A, Bonci A, Picetti R, Calabresi P, Bernardi G, Borrelli E: Loss of autoreceptor function in dopaminergic neurons from dopamine D2 receptor deficient mice. Neuroscience, 1997, 79, 323-327.
34. Montmayeur JP, Guiramand J, Borelli E: Preferential coupling between dopamine D2 receptors and G-proteins. Mol Endocrinol, 1993, 163, 161-170.
35. Nader MA, Czoty PW, Gould RW, Riddick NV: Positron emission tomography imaging studies of dopamine receptors in primate models of addiction. Philos Trans R Soc Lond B Biol Sci, 2008, 363, 3223-3232.
36. Oomizu S, Boyadjieva N, Sarkar DK: Ethanol and estradiol modulate alternative splicing of dopamine D2 receptor messenger RNA and abolish the inhibitory action of bromocriptine on prolactin release from the pituitary gland. Alcohol Clin Exp Res, 2003, 27, 975-980.
37. Phillips TJ, Brown KJ, Burkhart-Kasch S, Wenger CD, Kelly MA, Rubinstein M, Grandy DK et al.: Alcohol preference and sensitivity are markedly reduced in mice lacking dopamine D2 receptors. Nat Neurosci, 1998, 1, 610-615.
38. Presgraves SP, Ahmed T, Borwege S, Joyce JN: Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists. Neurotox Res, 2004, 5, 579-598.
39. Radhakishun FS, Van Ree JM: The hypomotility elicited by small doses of apomorphine seems exclusively mediated by dopaminergic systems in the nucleus accumbens. Eur J Pharmacol, 1987, 136, 41-47.
40. Randall S, Hannigan JH: In utero alcohol and postnatal methylphenidate: locomotion and dopamine receptors. Neurotoxicol Teratol, 1999, 21, 587-593.
41. Repo E, Kuikka JT, Bergström KA, Karhu J, Hiltunen J, Tiihonen J: Dopamine transporter and D2-receptor density in late-onset alcoholism. Psychopharmacology (Berl) 1999, 147, 314-318.
42. Samad TA, Krezel W, Chambon P, Borelli E: Regulation of dopaminergic pathways by retinoids: Activation of the D2 receptor promoter by members of the retinoic acid receptor-retinoid X receptor family. Proc Natl Acad Sci USA, 1997, 94,14349-14354.
43. Sari Y, Bell RL, Zhou FC: Effects of chronic alcohol and repeated deprivations on dopamine D1 and D2 receptor levels in the extended amygdala of inbred alcoholpreferring rats. Alcohol Clin Exp Res, 2006, 30, 46-56.
44. Schmidt LG, Dettling M, Graef KJ, Heinz A, Kuhn S, Podschus J, Rommelspacher H: Reduced dopaminergic function in alcoholics is related to severe dependence. Biol Psychiatry, 1996, 39, 193-198.
45. Schneider ML, Moore CF, Barnhart TE, Larson JA, DeJesus OT, Mukherjee J, Nickles RJ et al.: Moderatelevel prenatal alcohol exposure alters striatal dopamine system function in rhesus monkeys. Alcohol Clin Exp Res, 2005, 29, 1685-1697.
46. Schultz W: Getting formal with dopamine and reward. Neuron, 2002, 36, 241-263.
47. Seidenfaden R, Krauter A, Hildebrandt H: The neural cell adhesion molecule NCAM regulates neuritogenesis by multiple mechanisms of interaction. Neurochem Int, 2006, 49, 1-11.
48. Shen RY, Hannigan JH, Kapatos G: Prenatal ethanol reduces the activity of adult midbrain dopamine neurons. Alcohol Clin Exp Res, 1999, 23, 1801-1807.
49. Shetty AK, Burrows RC, Phillips DE: Alterations in neuronal development in the substantia nigra pars compacta following in utero ethanol exposure: immunohistochemical and Golgi studies. Neuroscience, 1993, 52, 311-322.
50. 3 receptors in offspring. Neurotoxicol Teratol, 2005, 27, 73-93.
51. Spanagel R, Weiss F: The dopamine hypothesis of reward: past and current status. Trends Neurosci, 1999, 22, 521-527.
52. Storch A, Ludolph AC, Schwarz J: HEK-293 cells expressing the human dopamine transporter are susceptible to low concentrations of 1-methyl-4-phenylpyridine (MPP) via impairment of energy metabolism. Neurochem Int, 1999, 35, 393-403.
53. Thanos PK, Volkow ND, Freimuth P, Umegaki H, Ikari H, Roth G, Ingram DK, Hitzemann R:. Overexpression of dopamine D2 receptors reduces alcohol self-administration. J Neurochem, 2001, 78, 1094-1103.
54. Thanos PK, Rivera SN, Weaver K, Grandy DK, Rubinstein M, Umegaki H, Wang GJ et al.: Dopamine D2R DNA transfer in dopamine D2 receptor-deficient mice: effects on ethanol drinking. Life Sci, 2005, 77, 130-139.
55. Thanos PK, Taintor NB, Rivera SN, Umegaki H, Ikari H, Roth G, Ingram DK et al.: DRD2 gene transfer into the nucleus accumbens core of the alcohol preferring and nonpreferring rats attenuates alcohol drinking. Alcohol Clin Exp Res, 2004, 28, 720-728.
56. Thibault C, Lai C, Wilke N, Duong B, Olive MF, Rahman S, Dong H et al.: Expression profiling of neural cells reveals specific patterns of ethanol-responsive gene expression. Mol Pharmacol, 2000, 58, 1593-1600.
57. Truckenmiller ME, Vawter MP, Cheadle C, Coggiano M, Donovan DM, Freed WJ, Becker KG: Gene expression profile in early stage of retinoic acid-induced differentiation of human SH-SY5Y neuroblastoma cells. Restor Neurol Neurosci, 2001, 18, 67-80.
58. Tupala E, Hall H, Mantere T, Rasanen P, Sarkioja T, Tiihonen J: Dopamine receptors and transporters in the brain reward circuits of type 1 and 2 alcoholics measured with human whole hemisphere autoradiography. Neuroimage, 2003, 19, 145-155.
59. Usiello A, Baik JH, Rouge-Pont F, Picetti R, Dierich A, LeMeur M, Piazza PV, Borelli E: Distinct functions of the two isoforms of dopamine D2 receptors. Nature, 2000, 408, 199-203.
60. Vasconcelos SM, Nascimento VS, Nogueira CR, Vieira CM, Sousa FC, Fonteles MM, Viana GS: Effects of haloperidol on rat behavior and density of dopaminergic D2-like receptors. Behav Processes, 2003, 63, 45-52.
61. Volkow ND, Wang GJ, Begleiter H, Porjesz B, Fowler JS, Telang F, Wong C et al.: High levels of dopamine D2 receptors in unaffected members of alcoholic families: possible protective factors. Arch Gen Psychiatry, 2006, 63, 999-1008.
62. Wise RA: Action of drugs of abuse on brain reward systems. Pharmacol Biochem Behav, 1980, 13 Suppl 1, 213-123.
63. Wise RA: Dopamine, learning and motivation. Nat Rev Neurosci, 2004, 5, 483-494.
64. Wise RA, Rompre PP: Brain dopamine and reward. Annu Rev Psychol, 1989, 40, 191-225.
65. Zapata A, Kivell B, Han Y, Javitch JA, Bolan EA, Kuraguntla D, Jaligam V et al.: Regulation of dopamine transporter function and cell surface expression by D3 dopamine receptors. J Biol Chem, 2007, 282, 35842-35854.
66. 3H-nisoxetine binding and norepinephrine transporter mRNA in SK-N-SHSY5Y cells. Brain Res Bull, 1999, 49, 291-295.